Background: A possible aetiological link between obesity and certain autoimmune diseases (ADs) has been suggested. We investigated the associations between body mass index (BMI, kg/m
Introduction
Obesity constitutes a serious health problem as reflected by the increased all-cause mortality among obese individuals. 1 Similarly, autoimmune diseases are among the leading causes of death among females in the UK 2 and the USA. 3 During the past decades Since 1980, a growing prevalence of obesity has been observed worldwide, [4] [5] [6] though perhaps reaching a plateau in the past years with more than one-third of adults being obese in the USA. 7 Today, obesity is considered a low-grade systemic inflammatory condition with elevated levels of inflammatory markers such as leptin, C-reactive protein, tumour necrosis factor-a and interleukin-6. 8 The pro-inflammatory adipokine, leptin, which is secreted excessively in obesity by adipocytes, has been identified as a potent immune modulator possibly playing an important role in the development of autoimmune diseases (ADs). [9] [10] [11] The pro-inflammatory effect of leptin seems to sustain autoreactive cell proliferation, thereby increasing the risk of AD. 10, 12 An association between obesity and various ADs has been suggested but prospective cohort studies on the subject are sparse. High BMI (body mass index, kg/m 2 ) has been suggested to relate to development and progression of rheumatoid arthritis (RA), [12] [13] [14] but results are inconsistent. 15 Likewise, BMI may associate with thyroid autoimmunity 16 and psoriasis 17, 18 but results are contradicting and many studies are based on BMI in patients with existing AD, hence containing risk of reverse causality. Children diagnosed with type 1 diabetes mellitus (T1DM) are increasingly overweight or obese 19, 20 but whether obesity among adults is associated with T1DM is still unknown. The only prospective study of the impact of BMI on risk of inflammatory bowel disease (IBD) showed no associations 21 as opposed to a previous retrospective study linking high BMI to Crohn's disease (CD). 22 Further, obesity or obesity-related immunological changes have been suggested in a limited number of studies to associate with other ADs, such as multiple sclerosis (MS), 23, 24 celiac disease 25, 26 and systemic lupus erythematosus (SLE). 27 The aim of this large-scale cohort study was to assess the relationship between pre-pregnancy BMI in Danish women of reproductive age and development of 43 different autoimmune diseases in the following decade, also considering the potential effect of weight changes in pregnancy and postpartum weight retention.
Methods

Ethical considerations
The study was purely register-and questionnaire-based without contact with participants and followed the regulations and instructions set up by the Danish Data Protection Agency (approval no. 2008-54-0472).
Study population
The study was based on just above 92 000 women originally enrolled in the Danish National Birth Cohort (DNBC) during 1996-2002. Recruitment by general practitioners took place in early pregnancy throughout Denmark. Women were asked to participate in telephone interviews during pregnancy and early motherhood. 28 In the present study, we used information from the first (16 weeks of gestation), second (30 weeks of gestation), and third (6 months after delivery) interview. A few women gave birth to more than one child in the period 1996-2002, but in the present study only information on BMI related to the first
Key Messages
• In this large population-based cohort study of 75 008 younger Danish women, we examined the association between BMI and 43 autoimmune diseases (ADs). BMI was found to be associated with some, but not all ADs.
• Most pronouncedly, obesity (BMI 30) was associated with increased risk of sarcoidosis (>3-fold) and type 1 diabetes mellitus (>2-fold).
• A higher risk of psoriasis and rheumatoid arthritis was observed in obese women, and the association between BMI and Crohn's disease showed a U-shaped pattern [obese and underweight women (BMI<18.5) being at increased risk].
• Inverse associations between BMI and celiac disease and Raynaud's phenomenon were observed.
• BMI did not seem to influence risk of multiple sclerosis or thyroid autoimmunity.
pregnancy registered in the DNBC was used as an exposure variable. Less than 1% (n¼748) of the cohort members were without complete information on confounders such as smoking and parity, and these women were excluded from the cohort. The final cohort consisted of 75 008 women; flow chart information can be viewed in Figure 1 .
Exposure
The exposure variable pre-pregnancy body mass index (kg/ m 2 ) was calculated from self-reported information on height ('How tall are you?') and pre-pregnancy weight ('What was your weight before the pregnancy?') in the first interview. Categories were based on the World Health Organization's BMI definitions where <18.5 kg/m 2 is considered underweight, 18. 
Statistical analysis
Women were followed from time of delivery until development of AD (first hospital contact), emigration, death or end of follow-up on 31 December 2011. By starting follow-up after delivery, ADs directly related to pregnancy were avoided to some extent. Hazard ratios (HRs) with 95% confidence intervals (CIs) of first hospitalization for an autoimmune disease were calculated using Cox proportional hazards models with the woman's age as underlying timescale. The proportional hazards assumption was evaluated in two ways for the 'any AD' fully adjusted model. The effect of BMI at age 40 years was compared with the effect of BMI at age >40 years using an interaction test. Furthermore, the empirical score process 32 follow-up (self-reported in the DNBC or register-based diagnosis) were excluded from the analyses of 'any AD', but not in the examination of each specific disease where women were allowed to have other ADs before start of follow-up and to contribute with more than one type of AD. Before enrolment, 5.3% (n ¼ 4005) of the women were registered as having at least one AD. Linear trend analyses using BMI as a continuous variable were performed for ADs with 5 cases and HRs per BMI unit were only estimated for diseases compatible with a linear trend. ADs with 50 cases in the cohort were categorized according to BMI (underweight, normal-weight, overweight, obese). HRs were estimated using normal weight as reference. All statistical tests were performed by Wald tests using SAS software version 9.3 (SAS Institute, Cary, NC, USA). In sensitivity analyses for the 13 most prevalent ADs, referred to in the following as restricted diagnosis analysis, we restricted AD outcomes to include only women recorded at least twice with the same AD diagnosis in the Danish National Patient Register using the date of AD diagnosis on the date of the second diagnosis. This served to increase the validity and specificity of recorded diagnoses. To evaluate gestational weight gain (GWG; as a surrogate for sudden weight gain, in kg, continuous variable) and postpartum weight retention (PPWR; as a surrogate for persistent weight gain, 3, 3-8, 8 kg) at 6 months after delivery as potential mediators, separate adjustments for these variables were performed for ADs either showing compatibility with a linear trend with BMI or statistically different estimates across BMI categories. In testing whether the possible mediator effect was affected by women excluded due to missing information about GWG and PPWR, the same analyses were performed for the corresponding cohorts without the adjustment for the two potential mediators (Appendix Table 4 , available as Supplementary data at IJE online).
Results
Overall, 75 008 women with a median age of 30.2 years (lower-upper quartile, 27.4-33.3 years) at start of followup were followed for a median of 11.4 years (lower-upper quartile; 10.2-12.5 years). The cohort consisted of women from all strata according to data on smoking, alcohol and socio-occupational status information, and 27.4% were overweight or obese (Table 2) .
During follow-up, 3.2% (n ¼ 2430) of the women developed at least one AD and 2607 new AD cases were recorded. The three most frequent ADs were Graves' disease (occurring in 0.8% of cohort members), ulcerative colitis (0.5%) and rheumatoid arthritis (0.4%). Co-occurrence of ADs was present in 303 women (0.4%); of these 270 had two, 31 had three and 2 women had five co-occurring ADs. In the relationship between BMI and later development of autoimmune disease, compatibility with a linear trend was found for all ADs except ankylosing spondylitis, ulcerative colitis and sarcoidosis. An increased risk of 14% (95% CI 1% to 30%) per BMI unit was found for dermatitis herpetiformis but was based on too few cases to be included in further analyses ( Figure 2 ). Below, results of mediator analyses are only mentioned when relevant, but all results can be viewed in the Appendix (available as Supplementary data at IJE online).
Any autoimmune disease Any autoimmune disease (n ¼ 2430) occurred at a median of 5.7 (2.8-8.6) years after start of follow-up. The risk of any autoimmune disease was increased in obese women (HR, 1.27; 95% CI, 1.11 to 1.46) compared with normal-weight women (Table 3) . Overall, a trend of linearity was observed for any autoimmune disease across BMI units (P trend < 0.01) with an increasing risk of 2% (95% CI, 1% to 2%) per BMI unit (Figure 2 ).
Celiac disease
Celiac disease showed a decreased risk of 7% (1-13%) per BMI unit increase (Figure 2) . Accordingly, the risk of celiac disease was increased in underweight women Reiter's disease, 1; rheumatic fever, 4; sympathetic ophthalmia, 0). Hazard ratios are only shown for diseases where the association between body mass index and the disease were compatible with a trend (not compatible with a trend: ankylosing spondylitis, ulcerative colitis and sarcoidosis).
(P trend ¼ 0.03) (HR 2.59; 95% CI, 1.27 to 5.26) ( Table 3 ).
In the restricted diagnosis analysis, no association between underweight and development of celiac disease was seen (P trend ¼ 0.07), however underweight women tended to have a 2-fold increased risk of celiac disease (HR 2.23; 95% CI, 0.79 to 6.33) although statistically insignificant (Table 3 ).
Crohn's disease Overall, no association was observed between BMI and
Crohn's disease (HR 1.00; 95% CI, 0.96 to 1.04, (Figure 2 ). However, performing restricted diagnosis analysis resulted in an increased risk in both underweight (HR 2.57; 95% CI, 1.30 to 5.06) and obese women (HR 1.88; 95% CI, 1.02 to 3.47) compared with normal-weight women, pointing to a U-shaped association (Table 3) .
Psoriasis
No linear associations between BMI and psoriasis were observed (HR 1.03; 95% CI, 0.99 to 1.07, P trend ¼ 0.14) (Figure 2 ), but when comparing BMI categories, an increased risk of psoriasis was seen in obese women (HR 2.16; 95% CI, 1.25 to 3.72) compared with normal-weight women (Table 3) . Further, trend of linearity in restricted diagnosis analysis (Table 3 ) was found (P trend ¼ 0.02) with a more than 3-fold risk of psoriasis in obese women (HR 3.03; 95% CI, 1.24 to 7.42).
Rheumatoid arthritis
Rheumatoid arthritis showed no overall linear association with BMI (HR 1.02; 95% CI, 0.99 to 1.05, P trend ¼ 0.08) (Figure 2 ) but an increased risk of rheumatoid arthritis was observed in obese women (HR 1.53; 95% CI, 1.07 to 2.18) compared with normal-weight women ( Table 3 ). The increased risk in obese women did, however, not persist in restricted diagnosis analysis (HR 1.09; 95% CI, 0.63 to 1.88) ( Table 3 ).
Raynaud's phenomenon
An inverse association between BMI and Raynaud's phenomenon was observed with a decreasing risk of 12% (4-19%) per BMI unit increase (P trend < 0.01) (Figure 2 ). Underweight women were at no increased risk of Raynaud's phenomenon, whereas overweight women appeared to be at a reduced risk (HR 0.23; 95% CI, 0.07 to 0.73) compared with normal-weight women ( Table 3) . The inverse association with overweight persisted when adjusting for GWG (HR 0.19; 95% CI, 0.05 to 0.80) and PPWR (HR 0.21; 95% CI, 0.05 to 0.86) (Appendix Table  4 , available as Supplementary data at IJE online). There were too few cases to estimate HRs in the restricted diagnosis analysis for overweight and obese women.
Sarcoidosis
Sarcoidosis showed the highest risk in obese women among all studied ADs but the association was not compatible with a linear trend. Heterogeneity between BMI and risk of sarcoidosis was observed across BMI categories (P homogeneity < 0.01) with an increased risk in overweight (HR 1.90; 95% CI, 1.27 to 2.84) and obese (HR 3.59; 95% CI, 2.31 to 5.57) women. Restricted diagnosis analysis (Table 3) showed a more than 2-fold increased risk of sarcoidosis in overweight (HR 2.26; 95% CI, 1.35 to 3.79) women and a more than 4-fold increased risk in obese women (HR 4.30; 95% CI, 2.47 to 7.50)(P homogeneity < 0.01).
Type 1 diabetes mellitus
The risk of T1DM increased by 7% (4-11%) per BMI unit increase (P trend < 0.01). Accordingly, a 2.7-fold increased risk was found in obese women (HR 2.67; 95% CI, 1.71 to 4.17) ( Table 3 ). In restricted diagnosis analyses, the association between BMI and T1DM remained with a 2-fold increased risk of T1DM among obese women (HR 2.01; 95% CI, 1.15 to 3.51). Adjusting for GWG showed no association in obese women (HR 1.66, 95% CI 0.96-2.85) and no linear trend was observed (P trend ¼ 0.12). Adjusting for PPWR did not change estimates (Appendix Table 4 , available as Supplementary data at IJE online).
Other frequent ADs
Risks of other frequent ADs, including ankylosing spondylitis, Graves' disease, Hashimoto's thyroiditis, ulcerative colitis, erythema nodosum, and multiple sclerosis were not associated with BMI.
Discussion
This large population-based cohort study of 75 008 Danish women suggests an association between BMI and development of several autoimmune diseases. Associations were found between increasing BMI and ADs in overall analyses for 'any AD', dermatitis herpetiformis and especially T1DM and sarcoidosis. Despite no overall trends, we also found a higher risk of psoriasis and rheumatoid arthritis in obese women. In restricted analyses, a U-shaped pattern between BMI and Crohn's disease was observed. Inverse associations between BMI and celiac disease and Raynaud's phenomenon were seen.
The primary strength of this study was the assessment of a well-characterized large cohort of women followed prospectively for more than a decade after collection of height and weight data and with detailed information on potentially important confounders and mediators such as smoking, alcohol, gestational weight gain and postpartum weight retention. Another advantage was the ability to exclude prevalent AD cases at baseline with high completeness due to access to both self-reported and register-based information. Additionally, we had access to information on BMI prior to diagnosis of ADs, hence avoiding recall bias. The use of interview data from DNBC combined with register information made it possible to investigate an exposure such as BMI, usually not accessible in registers, and outcomes covering 43 different ADs.
Nevertheless, the study also has limitations to consider. Diagnoses of ADs were extracted from a hospital register containing information on diagnoses from all Danish inpatient and outpatient settings. However, milder cases of some of the ADs are likely to be diagnosed and treated by general practitioners or specialists, which is why our findings may apply mainly to the more severe cases of AD. Onset of disease might have occurred sometime before hospital contact, but this is not likely to have influenced results markedly, as women were followed for more than 11 years and the median (lower-upper quartile) time from start of follow-up to diagnosis of an AD was 5.8 (2.9-8.6) years. Incidence of some autoimmune diseases such as thyroiditis, Sjö gren's disease and rheumatoid arthritis peak after age 50 years and a long follow-up period would be preferable, but most autoimmune diseases can be diagnosed at any age and many in the reproductive years. 3 Concerning validity of the Danish National Patient Register, the register includes information on all somatic hospital admissions sin 1977, with inclusion of outpatients and emergency patients in 1995. 33 For several of the ADs in question, e.g. T1DM, ulcerative colitis (UC), CD, MS and RA, the register has been validated. [34] [35] [36] [37] To further evaluate validity of the studied ADs, we performed sensitivity analyses with cases recorded at least twice with the same diagnosis. This had little impact on results, adding robustness to the results. Women of low socio-occupational status could be a source of selection bias as this group has previously been found underrepresented in the DNBC. 38 Also, cohort members of the DNBC have in a previous study been found somewhat healthier in terms of weight and smoking than the general population. However, odds ratios of three different associations, including BMI and risk of stillbirth, were not biased by non-participation in the DNBC. 39 This in combination with an assumed low rate of women dropping out from the DNBC due to symptoms of a yet undiagnosed AD, indicates that selection bias is unlikely to have influenced findings markedly. Another consideration in relation to selection bias worth mentioning is infertility. Studies suggest that clinical (and thereby possibly also subclinical) AD 40 and to a greater extent high/low BMI 41 are associated with infertility (i.e. less likely to be included in the DNBC). Potentially, this may create selection bias; however, as the association between subclinical AD (which is the focus variable in this context since women with diagnosed AD before start of follow-up were excluded from analyses of that specific AD) and infertility is still considered inconsistent, we consider a possible selection bias due to the exclusion of infertile women negligible and if anything only likely to underestimate our results. BMI was only measured at start of follow-up, but a recent study found that weight increased equally for all BMI categories in women from early adulthood throughout the following 18 years of life. 42 Further, adjustments for weight changes linked to pregnancy, as represented by GWG and PPWR, were performed and the only noticeable observed effect was for GWG in the association between BMI and T1DM. Correction for multiple testing was not applied in this study since we assessed hypotheses for specific autoimmune diseases, not only an overall association between BMI and 'any' autoimmune disease.
Sarcoidosis
Of all the ADs, the highest risk (more than 3-fold) in obese women was observed for sarcoidosis, a disease that, to our knowledge, has not previously been related to obesity besides increased BMI in patients with existing sarcoidosis. 43 The aetiology of sarcoidosis remains unknown but the disease involves immunological changes similar to those seen in obesity, including TNF-a production. 44, 45 Infectious agents, such as mycobacteria, have been suspected as cause of sarcoidosis but, more possibly, disease development may depend on a combination of genetic polymorphisms, the triggering antigen itself and immune system status 46 in which the changed immunology caused by obesity could play a role. Besides, hypothalamicpituitary locations of sarcoidosis are rare, 47 which is why it seems unlikely that the association is explained by an effect on the satiety centre in the hypothalamus that could lead to overnutrition and thereby obesity.
Type 1 diabetes mellitus
To our knowledge, the >2-fold increased risk of T1DM in obese adults (women) represents a novel finding, though misclassification between type 1 and type 2 diabetes mellitus should be considered. Most studies of obesity and T1DM development have been performed in children and adolescents already diagnosed with T1DM, in whom the prevalence of overweight and obesity at time of diagnosis is increasing despite the fact that weight loss often precedes T1DM diagnosis. 19, 20 The earliest disease mechanisms in T1DM are suggested to take place early in life, 48 perhaps even in utero because of maternal obesity-related immunological changes. Obesity is often passed on between generations and therefore it could be hypothesized that obesity in adult life and T1DM are linked, even though the disease was triggered already in utero due to maternal obesity. This theory is compatible with the observation that GWG seemed to be a mediator in the observed association.
Psoriasis
Although no overall linear increase per BMI unit was observed, we found a >2-fold increased risk of psoriasis in obese women when compared with normal-weight women. The lack of significance could be due to lack of power in the very obese group. Further, the trend was significant in the restricted diagnosis analysis with a >3-fold increased risk of psoriasis in obese women. Contrary to T1DM, a possible relationship between obesity and psoriasis has been more thoroughly investigated, e.g. high BMI in adolescent girls has been connected to later psoriasis hospitalization, 49 but often studied in patients with existing disease. 50 A previous prospective study within the Nurses'
Health Study II including 78 626 women followed for a 14-year period also found an association of similar strength between BMI and psoriasis. 51 The Nurses' Health Study was, however, based solely on self-reported psoriasis, whereas in the present study diagnoses were based on hospital diagnoses with exclusion of self-reported and register-based cases before start of follow-up, thereby strengthening the validity. Nevertheless, the two similar findings point to an association between obesity and development of psoriasis as has been observed in obese adolescents as well. At the molecular level, leptin and other adipokines have been suggested to be involved in the pathogenesis of psoriasis in overweight individuals 52 and further, leptin might serve as a marker of severity and chronicity in psoriasis. 53 
Rheumatoid arthritis
In our study, we found only a weak association between BMI and RA though obese women had a 1.5 increased risk of RA development compared with normal-weight women.
A recent review emphasized that the association between leptin/high BMI and RA is still questionable, 11 and the increased risk found in some case-control studies 13, 14 may reflect an increased risk of RA following obesity but possibly only valid in a subgroup of RA patients without auto-antibodies against cyclic citrullinated peptides; 54, 55 subgroups not possible to identify in our study.
Celiac disease and dermatitis herpetiformis
Interestingly, we found an increased risk of celiac disease in underweight women. This observation points towards reverse causation; however, evidence of overweight/obesity in patients at time of diagnosis of celiac disease is evolving. 25, 26, 56, 57 Against this, undiagnosed celiac disease or celiac disease diagnosed outside hospital settings might have caused underweight before registration of the celiac disease diagnosis in the Danish National Patient Register. Furthermore, dermatitis herpetiformis, which is closely associated with gluten sensitivity as in celiac disease, 58 showed the highest risk with increasing BMI (14% per BMI unit) among all investigated ADs. To our knowledge, the only previous study on BMI and dermatitis herpetiformis showed a linearly higher prevalence of this disease with increasing BMI among patients with untreated celiac disease, thereby supporting our results.
59
Crohn's disease We found an increased risk of CD in underweight women compared with normal weight, and an increased risk among obese women. In a recently published study by Chan and colleagues on BMI and development of IBD, the underweight category was not investigated. 21 Whether our results reflect an actual increased risk in underweight women and not reverse causation due to early diseaseinduced weight loss is unclear. In support of our findings, a U-shaped relationship of BMI and risk of CD was previously found in a retrospective study by Mendall and colleagues 22 who suggested that this might be caused by underweight women having a more severe subtype and obese a less severe subtype of CD. Further, Chan and colleagues found no associations between high BMI and later development of UC or CD. 21 This is in line with our results for UC but, in restricted diagnosis analysis of CD, we found a 1.9 increased risk of CD in obese women. Chan and colleagues mainly investigated late-onset IBD with a median age at recruitment between 50 and 53 years, which may represent IBD of a different pathogenesis compared with IBD diagnosed earlier in life as in our study. Moreover, the study did not adjust for gender or age, even though BMI has been found both gender-and agedependent when used as an indicator of body composition. 60 Alternatively, a possible role of the gut microbiome underlying the risk between BMI and CD should be considered, as the intestinal bacterial flora has been associated with obesity 61 and IBD in individuals with a genetic predisposition. 62 Our data do not permit a more detailed evaluation of this possibility.
Raynaud's phenomenon Our finding of a decreased risk of Raynaud's phenomenon with increasing BMI remains unexplained and has, to our knowledge, not previously been reported.
Multiple sclerosis and thyroid autoimmunity Lastly, and against expectations, MS was not found to be associated with BMI. Two former studies have shown an increased risk of MS in individuals who were obese in childhood 63 and adolescence, 23, 24 whereas no association with BMI at time of disease occurrence has been observed, 23 hence suggesting adolescence to be critical in determining risk of MS. Likewise, thyroid autoimmunity was not found to be associated with BMI though a connection with leptin and obesity has been suggested. 16 
Shared mechanisms?
Overall, the suggested association between BMI and development of ADs in this study could be linked to the finding that several ADs such as psoriasis, IBD, RA, T1DM and MS have been related to changes in adipokine and cytokine levels which are seen in obesity as well. 10, 11, 53 Except for MS and UC, this corresponds to our findings. Co-occurrence of several ADs has been suggested, including RA, autoimmune thyroiditis and T1DM, 64 hence supporting a common aetiology or shared risk factors. On the other hand, the study found an inverse association between RA and MS. Genetically this is supported by a study suggesting a shared risk allele between T1DM, RA and thyroiditis, but not MS. 65 To our knowledge, a shared genetic link between obesity and autoimmune diseases has not been investigated. Further, the modest effect of BMI on risk of 'any AD' may reflect that ADs comprise a too heterogeneous group of diseases to share BMI as a common aetiological factor. At the cellular level, the proliferation of regulatory T cells, which are known to dampen autoreactive responses under normal conditions, is suggested to be inversely correlated with leptin in early stages of autoimmune disease, and obesity has even been proposed to be an autoimmune disorder in itself. 11, 66 Additionally, recent research suggests Th17 cell expansion to be a prominent element of pro-inflammatory diseases in obesity 67 and has been found to be connected to autoimmune diseases such as RA, ankylosing spondylitis, SLE, MS, psoriasis and IBD. 68 Possibly, the unstable Th17 cells are converted into either Th1 or Th2 phenotype, causing Th1-or Th2-mediated autoimmune diseases. 68 Another hypothesis could be the fact that leptin levels have been found 2-to 3-fold higher in women compared with men due to a higher percentage of body fat in females at a given weight or BMI. 69 Along with a predominance of ADs in women, 70 this adds to the possible relationship between obesity and AD development.
In conclusion, this cohort study of young Danish women showed an increased risk of some but not all ADs in obese women, most notably for sarcoidosis and T1DM. These novel results are interesting in light of the rising prevalence of obesity and some ADs and may reflect obesity-related complex immunological changes leading to autoimmune reactions. Underlying mechanisms and observed associations need further investigation.
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